GL1X · GenesisL1 explorer

MolNFT v1 · #137423 · protein

Dlk in complex with inhibitor 5-(1-isopropyl-5-(1-(oxetan-3-yl) piperidin-4-yl)-1H-pyrazol-3-yl)-3-(TRIFLUOROMETHYL)PYRIDIN-2-amine (compound 7)

5VO2 · Mitogen-activated protein kinase kinase kinase 12: “Dlk in complex with inhibitor 5-(1-isopropyl-5-(1-(oxetan-3-yl)…”. X-ray diffraction, 1 ligand (9FV), 3 pockets (best druggability 0.60). MolNFT v1 #137423 on GenesisL1: 3D…

PDB
5VO2
Type
protein
Length
269 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mitogen-activated protein kinase kinase kinase 12
EC
2.7.11.25
UniProt
Q12852
Ligands
9FV
Pockets
3 · best druggability 0.60

Structure

x-ray diffraction · 1 distinct chain · 44% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMitogen-activated protein kinase kinase kinase 12 (EC 2.7.11.25)protein26944% helix, 16% strandQ12852

Ligands and binding sites

  • 9FV · 5-{5-[1-(oxetan-3-yl)piperidin-4-yl]-1-(propan-2-yl)-1H-pyrazol-3-yl}-3-(trifluoromethyl)pyridin-2-amine · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11260.600.85229FV
2800.410.7917empty
3590.290.7420empty

Compared structures

  • 5VO2 · DLK in complex with inhibitor 5-(1-isopropyl-5-(1-(oxetan-3-yl)piperidin-4-yl)-1H-pyrazol… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q12852 · AlphaFold monomer V2.0 prediction for mitogen-activated protein kinase kinase kinase 12… · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.